Clinical Trial Update: Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Y90-radioembolization with nivolumab in Asians with hepatocellular carcinoma. The study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: HepatoCellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING